Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts.
- G. Crossley, A. Boyle, H. Vitense, Yanping Chang, R. Mead
- Medicine
- Journal of the American College of Cardiology
- 8 March 2011
OBJECTIVES
The primary objective was to determine if wireless remote monitoring with automatic clinician alerts reduces the time from a clinical event to a clinical decision in response to… Expand
Long-term outcome with the automatic implantable cardioverter-defibrillator.
- R. Winkle, R. Mead, +5 authors T. Shipman
- Medicine
- Journal of the American College of Cardiology
- 1 May 1989
The automatic implantable cardioverter-defibrillator was implanted in 270 patients because of life-threatening arrhythmias over a 7 year period. There was a history of sustained ventricular… Expand
Remote Monitoring of Implantable Cardioverter Defibrillators:
- M. Schoenfeld, S. Compton, +4 authors L. Mongeon
- Medicine
- Pacing and clinical electrophysiology : PACE
- 1 June 2004
A prospective study evaluating the functionality and ease of use of the Medtronic CareLink® Network, “CareLink,” was conducted at ten investigational sites. This internet‐based remote monitoring… Expand
Chronic performance of an active fixation coronary sinus lead.
- G. Crossley, D. Exner, +4 authors S. Adler
- Medicine
- Heart rhythm
- 1 April 2010
BACKGROUND
Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in appropriately selected patients with heart failure. Optimal left ventricular (LV) lead placement is useful in… Expand
The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation.
- R. Winkle, R. Mead, Gregory Engel, R. Patrawala
- Medicine
- Heart rhythm
- 1 September 2011
BACKGROUND
Atrial fibrillation (AF) ablation requires transseptal puncture to gain entry to the left atrium (LA). On rare occasions, LA entry cannot be achieved or cardiac perforation results in… Expand
Low complication rates using high power (45-50 W) for short duration for atrial fibrillation ablations.
- R. Winkle, S. Mohanty, +9 authors J. Day
- Medicine
- Heart rhythm
- 1 February 2019
BACKGROUND
Many centers use radiofrequency (RF) energy at 25-35 W for 30-60 seconds. There is a safety concern about using higher power, especially on the posterior wall.
OBJECTIVE
The purpose of… Expand
Predicting atrial fibrillation ablation outcome: The CAAP-AF score.
- R. Winkle, J. Jarman, +4 authors R. Patrawala
- Medicine
- Heart rhythm
- 1 November 2016
BACKGROUND
Patients with a variety of clinical presentations undergo atrial fibrillation (AF) ablation. Long-term ablation success rates can vary considerably.
OBJECTIVE
The purpose of this study… Expand
Long-term results of atrial fibrillation ablation: the importance of all initial ablation failures undergoing a repeat ablation.
- R. Winkle, R. Mead, G. Engel, R. Patrawala
- Medicine
- American heart journal
- 1 July 2011
BACKGROUND
Ablation is more successful for patients with paroxysmal atrial fibrillation (AF1) than for those with persistent (AF2) or longstanding persistent AF (AF3). Many patients fail initial… Expand
Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation
- R. Winkle, R. Mead, G. Engel, Melissa H. Kong, R. Patrawala
- Medicine
- Europace : European pacing, arrhythmias, and…
- 6 February 2012
Aims Atrial fibrillation (AF) ablation is generally performed after patients fail antiarrhythmic drug (AAD) therapy. Some patients have drug contraindications or choose to avoid a lifetime of drug… Expand
Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias.
- M. Ruder, T. Ellis, C. Lebsack, R. Mead, N. Smith, R. Winkle
- Medicine
- Journal of the American College of Cardiology
- 1989
Sixty-five patients with symptomatic, drug-refractory, sustained ventricular tachycardia or fibrillation were treated with oral sotalol (80 to 480 mg twice daily). Sotalol was withdrawn in 11… Expand